Literature DB >> 11013470

Giant prosthesis for reinforcement of visceral sac for complex bilateral and recurrent inguinal hernias: a prospective evaluation.

V Thapar1, P Rao, R Prabhu, C Desai, A S Singh, A N Supe.   

Abstract

AIMS: To evaluate giant prosthesis for reinforcement of visceral sac (GPRVS) as a treatment for complex bilateral and recurrent inguinal hernias. SUBJECTS AND METHODS: The prospective study carried out in a single surgical unit at a tertiary health care center involved consecutive series of 31 patients with complex bilateral and recurrent inguinal hernias who underwent GPRVS. All were men and the mean age was 58 years (range 49-95 years). Factors predicting high risk for recurrence included a large hernia ( greater, similar5cms, 32%, 10/31 patients), failure of one or more previous repairs (45%, 14/31 patients), chronic obstructive pulmonary disease (25%, 8/31 patients) and poor muscle tone (70%, 22/31 patients). Operative time, length of postoperative stay, complications and death were the main outcome measures.
RESULTS: Mean -/+ SEM operative time was 65 -/+ 11 minutes (range 45-115 minutes). Mean -/+ SEM length of stay was 3.5 -/+ 0.7 days (range 2-5 days). There were 4 minor complications, but no mesh infections and death. Follow up was obtained for a mean period of 14.6 months (range 12-23 months); there were no recurrences.
CONCLUSION: GPRVS provides a definitive and safe cure for repair of complex bilateral and recurrent inguinal hernias because of its simplicity, ease of the procedure, good results and low recurrence rate.

Entities:  

Mesh:

Year:  2000        PMID: 11013470

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  2 in total

1.  Inguinal hernia repair in a community setting: implications for the elderly.

Authors:  F B Rogers; E A Guzman
Journal:  Hernia       Date:  2010-10-09       Impact factor: 4.739

2.  Retrospective analysis of open preperitoneal mesh repair of complex inguinal hernias.

Authors:  Z Malazgirt; K Yildirim; I Karabicak; M F Gursel; A Acikgoz; H Ozturk
Journal:  Hernia       Date:  2022-04-05       Impact factor: 2.920

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.